CLINICAL_TRIALS
trial_result
· 2024-04-11
Clinical Trial Update: Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis [Phase 2]
Summary
Phase 2 clinical trial assessing early bactericidal activity of TBA-7371 in pulmonary tuberculosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gates Medical Research Institute | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2024-04-11